Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice
Restricted accessResearch articleFirst published online February, 1999
Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice
The hormonal activity of natural estrogens is influenced by the degree to which they bind to serum proteins. In the pregnant female and in the fetus, greater than 99% of estradiol may be bound by serum binding proteins. Therefore, even though total serum levels of estradiol appear very high in fetuses, we have found that in rodent fetuses, there is a very low free concentration of estradiol (0.2 pg/ml). Naturally occurring variation in fetal serum estradiol predicts differences in numerous postnatal traits, including prostate size. In addition, when this low level of free estradiol was experimentally increased from 0.2 to 0.3 pg/ml during the last third of fetal life, treated male mice showed an increase in adult prostate weight. Fetal exposure to low doses of xenobiotic estrogens by feeding to pregnant females, including the compounds methoxychlor (20 and 2000 μg/kg body weight), DES (0.02 to 2 μg/kg body weight) and bisphenol A (2 and 20 μg/kg body weight), also led to increased prostate weight in adulthood. In contrast, fetal doses of natural estradiol and DES above the physiological range of estrogenic activity, and within a toxicological dose range, led to the opposite outcome, a reduction in subsequent adult prostate weight. This indicates that it may be impossible to assess endocrine-disrupting activities in response to low doses within a physiological range of activity by using high, toxic doses of xenoestrogens in testing procedures. We have developed approaches in vitro to predict the potential estrogenic bioactivity of compounds in the physiologically relevant range in animals and humans. We address the following factors in predicting the final observed endocrine-disrupting effect in the animal: (1) the intrinsic estrogenic activity of a given molecule, (2) the effective free concentration determined by how the molecule is carried in serum, (3) partitioning between aqueous and lipid compartments in body and cell lipids, and (4) absorption and metabolism relative to the route of exposure. The studies and strategies we describe are important in developing criteria for a tiered testing system for the detection of estrogenic chemicals as well as endocrine-disrupting chemicals with different modes of action.
ATSDR (1994). Toxicological profile for methoxychlor. Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA.
2.
Bern, H. A. (1992). “The fragile fetus.” In: Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection (T. Colborn and C. Clement, eds.). Princeton Scientific Publishing, Princeton, NJ. pp. 9-15.
3.
Bulger, W., Mucitelli, R. M., and Kupfer, D. (1978). “Studies on the in vivo and in vitro estrogenic activities of methoxychlor and its metabolites: Role of hepatic mono-oxygenase in methoxychlor activation.”Biochem. Pharmacol.27:2417-2423.
4.
Colborn, T. and Clement, C. (eds.) (1992). Chemically-Induced Alterations in Sexual and Functional Development. Princeton Scientific Publishing, Princeton, NJ.
5.
Colborn, T., Vom Saal, F. S., and Soto, A. M. (1993). “Developmental effects of endocrine-disrupting chemicals in wildlife and humans.”Environ. Health Perspect.101:378-384.
6.
Dillon, J. C., Martin, G. B., and O'brien, H. T. (1981). “Pesticide residues in human milk.”Fd. Cosmet. Toxicol.19:437-442.
7.
Ekbom, A., Hsieh, C. C., Lipworth, L., Adami, H. Q., and Trichopoulos, D. (1997). “Intrauterine environment and breast cancer risk in women: A population-based study.”J. Natl. Cancer Inst.89:71-76.
8.
Ekins, R., Edwards, R., and Newman, B. (1982). “Free hormones in blood.” In: Free Hormones in Blood (A. Albertini and R. Ekins, eds.). Elsevier Biomedical Press, New York, NY, p. 3-3.
9.
Grady, L. H., Nonneman, D. J., Rottinghaus, G. E., and Welshons, W. V. (1991). “pH-Dependent cytotoxicity of contaminants of phenol red for MCF-7 breast cancer cells.”Endocrinology129:3321-3330.
10.
Gray et al., herein.
11.
Imagawa, W., Yang, J., Guzman, R., and Nandi, S. (1994). “Control of mammary gland development.” In: Physiology of Reproduction: Volume 2 (E. Knobil, J. Neill and D. Pfaff, eds.). Raven Press, New York, NY. pp. 1033-1063.
12.
Jensen, A. A. and Slorach, S. A. (1991). Chemical Contaminants in Human Milk. CRC Press, Boston, MA.
13.
Jordan, V. C. and Murphy, C. S. (1990). “Endocrine pharmacology of antiestrogens as antitumor agents.”Endocr. Rev.11:578-610.
14.
Judy, B. M. and Welshons, W. V. (1998). “Cellular localization of receptors mediating actions of steroid hormones.” In: Handbook of Physiology, Section 7: The Endocrine System, Volume 1: Cellular Mechanisms (P. M. Conn, ed.). American Physiology Society, New York, NY. pp. 437-460.
15.
Lubahn, D. B., Ghosh, D., Taylor, J. A., and Green, K. A. (1998). “Methoxychlor stimulates estrogen responsive messenger RNAs in mouse uterus through a non-ER α and ERβ mechanism.” In: Meeting on Endocrine Disrupting Chemicals sponsored by the Japanese Environmental Agency, Kyoto, Japan, December, 1998.
16.
Lucier, G. W., Portier, C. J., and Gallo, M. A. (1993). “Receptor mechanisms and dose-response models for the effects of dioxins.”Environ. Health Perspect.101:36-44.
17.
McLachlan, J., Newbold, R., and Bullock, B. (1975). “Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol.”Science190:991-992.
18.
Mendel, C. (1989). “The free hormone hypothesis: A physiologically based mathematical model.”Endocr. Rev.10:232-274.
19.
Montano, M. M., Welshons, W. V., and Vom Saal, F. S. (1995). “Free estradiol in serum and brain uptake of estradiol during fetal and neonatal sexual differentiation in female rats.”Biol. Reprod.53:1198-1207.
20.
Nagel, S. C., Vom Saal, F. S., Thayer, K. A., Dhar, M. G., Boechler, M., and Welshons, W. V. (1997). “Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.”Environ. Health Perspect.105:70-76.
21.
Nagel, S. C., Vom Saal, F. S., and Welshons, W. V. (1998). “The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: Physiology of delivery modifies estrogenic activity.”Proc. Soc. Exp. Biol. Med.217:300-309.
22.
Nonneman, D. J., Ganjam, V. K., Welshons, W. V., and Vom Saal, F. S. (1992). “Intrauterine position effects on steroid metabolism and steroid receptors of reproductive organs in male mice.”Biol. Reprod.47:723-729.
23.
Rogan, W. J., Gladen, B. C., McKinney, J. D., Carreras, N., Hardy, P., Thullen, J., Tingelstad, M. D., and Tully, M. (1987). “Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: Effects on growth, morbidity, and duration of lactation.”Am. J. Public Health77:1294-1297.
24.
Santti, R., Newbold, R. R., Makela, S., Pylkkanen, L., and McLachlan, J. A. (1984). “Developmental estrogenization and prostatic neoplasia.”The Prostate24:67-78.
25.
Shah, H. C. and McLachlan, J. A. (1976). “The fate of diethylstilbestrol in the pregnant mouse.”J. Pharmacol. Exp. Ther.197:687-696.
26.
Sheehan, D. and Young, M. (1979). “Diethylstilbestrol and estradiol binding to serum albumin and pregnancy plasma of rat and human.”Endocrinology104:1442-1446.
27.
Skalsky, H. L. and Guthrie, F. E. (1978). “Binding of insecticides to human serum proteins.”Toxicol. Appl. Pharmacol.43:229-235.
28.
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., and Korach, K. S. (1994). “Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.”N. Engl. J. Med.331:1056-1061.
29.
Society of the Plastics Industry (1996). Report on the potential exposures to bisphenol A from epoxy can coatings. Society of the Plastics Industry, Washington, DC.
30.
Soto, A. M., Justicia, H., Wray, J. W., and Sonnenschein, C. (1991). “p-Nonyl-phenol: An estrogenic xenobiotic released from `modified' polystyrene.”Environ. Health Perspect.92:167-173.
31.
Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandes, N. O., and Serrano, F. O. (1995). “The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants.”Environ. Health Perspect.103:113-122.
32.
Thomas, K. and Colborn, T. (1992). “Organochlorine endocrine disruptors in human tissue.” In: Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection (T. Colborn and C. Clement, eds.). Princeton Scientific Publishing, Princeton, NJ. pp. 365-394.
33.
Vom Saal, F. S. (1989). “Sexual differentiation in litter-bearing mammals: Influence of sex of adjacent fetuses in utero.”J. Anim. Sci.67:1824-1840.
34.
Vom Saal, F. S. and Sheehan, D. M. (1998). “A challenge to risk assessment posed by low dose effects of endocrine disrupting environmental chemicals.”Forum Appl. Res. Public Policy, 11-18.
35.
Vom Saal, F. S., Montano, M. M., and Wang, H. S. (1992). “Sexual differentiation in mammals.” In: Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection (T. Colborn and C. Clement, eds.). Princeton Scientific Publishing, Princeton, NJ. pp. 17-83.
36.
Vom Saal, F. S., Finch, C. E., and Nelson, J. F. (1994). “Natural history and mechanisms of aging in humans, laboratory rodents and other selected vertebrates.” In: Physiology of Reproduction, Volume 2 (E. Knobil, J. Neill, and D. Pfaff, eds.). Raven Press, New York, NY. pp. 1213-1313.
37.
Vom Saal, F. S., Nagel, S. C., Palanza, P., Boechler, M., Parmigiani, S., and Welshons, W. V. (1995). “Estrogenic pesticides: Binding relative to estradiol in MCF-7 cells and effects of exposure during fetal life on subsequent territorial behavior in male mice.”Toxicol. Lett.77:343-350.
38.
Vom Saal, F. S., Timms, B. G., Montano, M. M., Palanza, P., Thayer, K. A., Nagel, S. C., Dhar, M. D., Ganjam, V. K., Parmigiani, S., and Welshons, W. V. (1997). “Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses.”Proc. Natl. Acad. Sci. USA94:2056-2061.
39.
Vom Saal, F. S., Cooke, P. S., Palanza, P., Thayer, K. A., Nagel, S., Parmigiani, S., and Welshons, W. V. (1998). “A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior.”Toxicol. Ind. Health14:239-260.
40.
Vom Saal, F. S., Clark, M. M., Galef, B. G., Drickamer, L. C., and Vandenbergh, J. G. (1999). “The intrauterine position (IUP) phenomenon.” In: Encyclopedia of Reproduction (E. Knobil and J. Neill, eds.). Academic Press, New York, NY (in press).
41.
Welshons, W. V. and Jordan, V. C. (1987). “Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture.”Eur. J. Cancer Clin. Oncol.23:1935-1939.
42.
Welshons, W. V., Murphy, C. S., Koch, R., Calaf, G., and Jordan, V. C. (1987). “Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol.”Breast Cancer Res. Treat.10:169-175.
43.
Welshons, W. V., Rottinghaus, G. E., Nonneman, D. J., Dolan-timpe, M., and Ross, P. F. (1990). “A sensitive bioassay for detection of dietary estrogens in animal feeds.”J. Vet. Diagn. Invest.2:268-273.
44.
Welshons, W. V., Engler, K. S., Taylor, J. A., Grady, L. H., and Curran, E. M. (1995). “Lithium-stimulated proliferation and alteration of phosphoinositide metabolites in MCF-7 human breast cancer cells.”J. Cell Physiol.165:134-144.
45.
White, R., Jobling, S., Hoare, S. A., Sumpter, J. P., and Parker, M. G. (1994). “Environmentally persistent alkylphenolic compounds are estrogenic.”Endocrinology135:175-182.
46.
Yang, N. N., Venugopalan, M., Hardikar, S., and Glasebrook, A. (1996). “Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene.”Science273:1222-1225.
